Wearable dialysis: What is missing?

Contributions to Nephrology

Volumn 171, Issue , 2011, Pages 226-230

  Polaschegg, Hans Dietrich ^a  

^a Medical Devices Consultant ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL KIDNEY; HUMAN;

HUMANS; KIDNEY, ARTIFICIAL;

EID: 79958096452     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000327231     Document Type: Article

References (26)

1. Jacobsen SC, Stephen RL, Bulloch EC, Luntz RD, Kolff WJ: A wearable artificial kidney: functional description of hardware and clinical results. Proc Clin Dial Transplant Forum 1975;5: 65-71.
2. Stephen RL, Jacobsen SC, Kablitz C, Kolff WJ: Combined technologicalclinical approach to wearable dialysis. Kidney Int Suppl 1978;8:S125-S132.
3. Shaldon S, Beau MC, Deschodt G, Lysaght MJ, Ramperez P, Mion C: Continuous ambulatory hemofiltration. Trans Am Soc Artif Intern Organs 1980;26:210-212.
4. Takai I, Shinzato T, Morita H, Fujita Y, Inoue I, Kobayakawa H, Maeda K: A new treatment strategy using both intermittent short dialysis and continuous ambulatory hemofiltration. ASAIO J 1991;37:M325-M327.
5. Stephens RL, Jacobsen SC, Atkin- thor E, Kolff W: Portable/wearable artificial kidney (WAK) - initial evaluation. Proc Eur Dial Transplant Assoc 1975;12:511-518.
6. Gura V, Beizai M, Ezon C, Polaschegg HD: Continuous renal replacement therapy for end- stage renal disease: the wearable artificial kidney (WAK). Contrib Nephrol 2005;149:325-333. (Pubitemid 43265029)
7. Davenport A, Gura V, Ronco C, Beizai M, Ezon C, Rambod E: A wearable haemodialysis device for patients with end- stage renal failure: a pilot study. Lancet 2007;370:1977-1978.
8. Gura V, Macy AS, Beizai M, Ezon C, Golper TA: Technical breakthroughs in the wearable artificial kidney (WAK). Clin J Am Soc Nephrol 2009; 4:1441-1448.
9. Roberts M, Guziel LP, Yanagawa N, Lee DBN: Towards a wearable artificial kidney: customizing the sorbent cartridge. ASAIO J 2001;47:151.
10. Cafazzo JA, Leonard K, Easty AC, Rossos PG, Chan CT: Patientperceived barriers to the adoption of nocturnal home hemodialysis. Clin J Am Soc Nephrol 2009;4:784-789.
11. Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, Lockridge RS Jr, Frequent Hemodialysis Network Trial Group: Recruitment and training for home hemodialysis: experience and lessons from the nocturnal dialysis trial. Clin J Am Soc Nephrol 2010;5:1614-1620.
12. Sodemann K, Polaschegg HD, Feldmer B: Two years' experience with Dialock® and CLS TM (a new antimicrobial lock solution). Blood Purif 2001;19:251-254. (Pubitemid 32041363)
13. Betjes MG, van Agteren M: Prevention of dialysis catheter- related sepsis with a citrate- taurolidinecontaining lock solution. Nephrol Dial Transplant 2004;19:1546-1551. (Pubitemid 38786749)
14. Taylor C, Cahill J, Gerrish M, Little J: A new haemodialysis catheter- locking agent reduces infections in haemodialysis patients. J Ren Care 2008;34: 116-120.
15. Schenk P, Rosenkranz AR, Wolfl G, Horl WH, Traindl O: Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Am J Kidney Dis 2000;35:130-136. (Pubitemid 30027250)
16. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, LeBlanc M, Faris P, Barre P, Zhang J, Scott- Douglas N, Prevention of Dialysis Catheter Lumen Occlusion with rt- PA versus Heparin Study Group: Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011;364:303-312.
17. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A: Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004;72:6023-6031. (Pubitemid 39303717)
18. National Safety Council, et al: Unintentional injury statistics. www. umm.edu/non-trauma/stats.htm (accessed March 3, 2011).
19. European Committee for Electrotechnical Standardization (CENELEC): Medical electrical equipment in medical practice. Part 2- 16: Particular requirements for basic safety and essential performance of haemodialysis, haemodiafiltration and haemofiltration equipment (IEC 60601 2-16, 2008- 04). www.cenelec.eu.
20. Meinhardt JP, Annich GM, Miskulin J, Kawai T, Ashton BA, Bartlett RH: Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation. ASAIO J 2003;49:395-400. (Pubitemid 36898977)
21. Clementi A, Floris M, Basso F, Kim JC, Garzotto F, Zanella M, Nalesso F, Brendolan A, Ronco C: The wearable artificial kidney: the voice of patients. Poster 31, World Conf Portable Wearable Miniaturized Syst Dialysis Ultrafitration, Vicenza, 30 September to 2 October 2010. www. vicenzanephrocourses. com/system/conferences/ downloads/programme-2010-2.pdf (accessed March 3, 2011).
22. Gault MH, Duffett S, Purchase L, Murphy J: Hemodialysis intravascular hemolysis and kinked blood lines. Nephron 1992;62:267-271.
23. Baxter Healthcare Corporation: Proper Routing of Blood Tubing Set for Meridian Instruments to Prevent Potential Kinking (Product Codes: 5M5576 and 5M5576R). Product Recall, Sep 28 2005.
24. Agar JW: International variations and trends in home hemodialysis. Adv Chronic Kidney Dis 2009;16:205-214.
25. Polaschegg HD: Red blood cell damage from extracorporeal circulation in hemodialysis. Semin Dial 2009;22: 524-531.
26. ASTM International: Standard Practice for Assessment of Hemolysis in Continuous Flow Blood Pumps (ASTM F1841- 97 2005). www.astm. org.